More from Episode 102:

Doc-in-a-Box and the Future of Diagnostics - Part 1

New Avenues to Prevent and Treat Cancer - Part 1

New Avenues to Prevent and Treat Cancer - Part 2

Personalized Medicine

Doc-in-a-Box and the Future of Diagnostics - Part 2

The Biodesign Institute is designing a system that could allow for faster detection of diseases — even before patients experience symptoms. The “Doc-in-a-Box” system would initially be limited to physician’s offices but could eventually be available for home use. Current blood tests typically measure a handful of indicators based on what the physician believes is the likely diagnosis. Using only a tiny blood sample, this device would allow far more comprehensive testing — i.e., thousands of indicators — from a single sample. If done regularly, this would allow more accurate and rapid diagnosis of disease.

Panelists include: George Poste, DVM, Ph.D., Director, the Biodesign Institute; Robert Penny, M.D., Ph.D., Chairman/CEO, Molecular Profiling Institute; and Nobel Laureate Lee Hartwell, Ph.D., President, Fred Hutchinson Cancer Research Center. Guest interviews include: Stephen Albert Johnston, Ph.D., the Biodesign Institute.